San Jose Mercury News: California Stem Cell Agency Eyeing More Bonds but Has No Treatments
In an overview of the $3 billion California stem cell agency, the San Jose Mercury News says that CIRM "still has no treatments on the market and is at a critical juncture that could determine how much longer it stays in operation. "
The story is the second significant piece about CIRM this week in a major California newspaper, which has not received muc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.